Democrats have a plan to cap insulin at $35 a month. Republicans won't say if they'll block it.

It is an open question whether Democrats will pass their Build Back Better bill this year, or ever — Sen. Joe Manchin (D-W.Va.) reiterated his ambivalence on Monday, even as he and President Biden spoke about the bill on the phone. But the version of the legislation that passed the House and is working its way through the Senate would cap insulin costs at $35 a month for people with insurance, either private or through Medicaid. Biden touted this provision of the bill last week.
"But it's a pledge Democrats may be unable to keep" to struggling diabetics, even if Manchin signs off, The Washington Post reports. "Senate Republicans are eyeing a procedural move to prevent the insulin cap from applying to privately insured Americans, seeking to deny Democrats a talking point heading into next year's midterm elections — even if it means that some patients will go without relief."
Facing lockstep GOP opposition to the expansive legislation, Senate Democrats plan to pass the bill through the budget reconciliation process. "Senate Republicans repeatedly declined to comment on whether they would use the 'Byrd rule' — which governs legislation enacted through the budget process — to knock out part of Biden's insulin plan," the Post reports. "Republicans have been meeting with the Senate parliamentarian to determine whether the bill's health provisions would technically qualify under budget reconciliation," and "if Senate Republicans challenge the insulin provision," and the parliamentarian sides with them, they "could call a point of order to strip the provision from the bill."
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Senate Republicans, and former President Donald Trump, supported lowering insulin prices that have shot up in recent years for no discernable reason. They could decide not to challenge the plan in the Build Back Better legislation. Some progressive Democrats, on the other hand, are urging Senate Democrats to expand the plan to include the uninsured.
"As I researched this topic, I found that 25 to 30 percent of Americans ration their insulin because of high cost," S. Vincent Rajkumar, a Mayo Clinic physician, tells the Post. "The ability to keep increasing the price every year on the same product happens only when there is no market force" to keep drugmakers in check. Read more at The Washington Post.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Peter has worked as a news and culture writer and editor at The Week since the site's launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University.
-
Colleges are canceling affinity graduations amid DEI attacks but students are pressing on
In the Spotlight The commencement at Harvard University was in the news, but other colleges are also taking action
-
When did computer passwords become a thing?
The Explainer People have been racking their brains for good codes for longer than you might think
-
What to know before 'buying the dip'
the explainer Purchasing a stock once it has fallen in value can pay off — or cost you big
-
RFK Jr. scraps Covid shots for pregnant women, kids
Speed Read The Health Secretary announced a policy change without informing CDC officials
-
Women need more pain management during gynecological procedures
Under the radar Pain should no longer be ignored
-
New FDA chiefs limit Covid-19 shots to elderly, sick
speed read The FDA set stricter approval standards for booster shots
-
US overdose deaths plunged 27% last year
speed read Drug overdose still 'remains the leading cause of death for Americans aged 18-44,' said the CDC
-
Trump seeks to cut drug prices via executive order
speed read The president's order tells pharmaceutical companies to lower prescription drug prices, but it will likely be thrown out by the courts
-
Protein obsession is oversaturating the health food space
Under the Radar Some experts say that fiber is now the most important macro to focus on
-
RFK Jr. visits Texas as 2nd child dies from measles
Speed Read An outbreak of the vaccine-preventable disease continues to grow following a decade of no recorded US measles deaths
-
Shingles vaccine cuts dementia risk, study finds
Speed Read Getting vaccinated appears to significantly reduce the chances of developing Alzheimer's and other forms of dementia